Prophylactic Ureteric Stents in Renal Transplant Recipients

A Multicenter Randomized Controlled Trial of Early Versus Late Removal

P. Patel; I. Rebollo-Mesa; E. Ryan; M. D. Sinha; S. D. Marks; N. Banga; I. C. Macdougall; M. C. Webb; G. Koffman; J. Olsburgh


American Journal of Transplantation. 2017;17(8):2129-2138. 

In This Article


In our study, early TUS removal on day 5 after transplantation significantly reduced stent complications—importantly, UTIs—in the first 3 mo after transplantation. Early stent removal also resulted in significantly improved QoL for patients. We recommend early stent removal for living donor transplants and for recipients of kidneys from standard criteria donors after brainstem death. The pediatric population potentially has the most to gain with early stent removal by removing the need for a general anesthesia procedure, although a limit in terms of patient weight and catheter size may be appropriate.

A nonsignificant increase in the rate of MUCs was seen; however, a study to assess this may not be feasible with the large numbers of patients required. Although the optimal duration remains to be determined and further studies assessing stenting for 1–4 weeks may be required to answer this, early stent removal is beneficial in terms of QoL, stent complications, and use of resources.